Literature DB >> 9126985

Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.

X Tao1, C Grant, S Constant, K Bottomly.   

Abstract

The adaptive immune responses to foreign Ags are primarily regulated by the cytokines produced by CD4 T cells. The generation of distinct cytokine-producing T cell subsets has been shown to be influenced by a number of factors, including cytokines, different types of APCs, and the amounts of priming Ag. We have previously reported that the affinity of an antigenic peptide for its presenting MHC class II molecules and that different doses of Ag peptide affect the outcome of the functional CD4 T cell response. In the current study, we further examined the impact of the affinity of an antigenic peptide for its TCR on CD4 T cell priming. We generated a panel of Ag peptide variants mutated at positions known to be critical for binding to a well-characterized TCR (known as altered peptide ligands, or APLs). Compared with the WT peptide, these APLs are defective in stimulating the proliferative responses of T cells. However, they can effectively prime in vitro naive CD4 T cells for differentiation into both Th1-like and Th2-like cells. In contrast, the WT peptide primes only for IFN-gamma-producing Th1-like cells. Using highly purified dendritic cells as APCs to present the APL or WT peptide leads to the same pattern of priming as using total splenic APCs. These results indicate that priming by APLs for both IL-4 production and IFN-gamma production does not require two different types of APCs. In summary, our data indicate that APL can directly stimulate naive CD4 T cells to become Th2 effector cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126985

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection.

Authors:  J D Ahlers; I M Belyakov; E K Thomas; J A Berzofsky
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.

Authors:  S M Anderton
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

3.  Functional plasticity of an antigen-specific memory CD4 T cell population.

Authors:  Mojgan Ahmadzadeh; Donna L Farber
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

Review 4.  How are T(H)2-type immune responses initiated and amplified?

Authors:  William E Paul; Jinfang Zhu
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

5.  Immunity to a self-derived, channel-forming peptide in the respiratory tract.

Authors:  Frederik W van Ginkel; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

Review 6.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

7.  Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Authors:  Xizhang Sun; Alice Wiedeman; Nalini Agrawal; Thomas H Teal; Lena Tanaka; Kelly L Hudkins; Charles E Alpers; Silvia Bolland; Matthew B Buechler; Jessica A Hamerman; Jeffrey A Ledbetter; Denny Liggitt; Keith B Elkon
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

8.  Attenuated T cell responses to a high-potency ligand in vivo.

Authors:  Emily Corse; Rachel A Gottschalk; Michelle Krogsgaard; James P Allison
Journal:  PLoS Biol       Date:  2010-09-14       Impact factor: 8.029

9.  TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.

Authors:  Rachel A Gottschalk; Emily Corse; James P Allison
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

10.  Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.

Authors:  Barbara A Sullivan; Niranjana A Nagarajan; Gerhard Wingender; Jing Wang; Iain Scott; Moriya Tsuji; Richard W Franck; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.